Validation of an HPLC method for quantification of anti-inflammatory markers in an ethanolic extract of Sahastara and its anti-inflammatory activity in vitro
Abstract
Background and purpose: Sahastara (SHT) is a traditional Thai medicine for the treatment of musculoskeletal and joint pain. It consists of 21 plant components. A previous study demonstrated the anti-inflammatory activity of SHT on inhibition of nitric oxide production and prostaglandin E2 (PGE2) production, however, inhibitory effects on tumor necrosis factor-alpha (TNF-α) has not been reported. In this study, we evaluated the anti-inflammatory activity of SHT on inhibitory effects on TNF-α and PGE2 production and presented an analytical method for validation of SHT.
Experimental approach: Anti-inflammatory activity was evaluated by inhibitory activity on TNF-α and PGE2 production in RAW264.7 cells. The validated procedure was conducted according to ICH guidelines. The validated parameters were specificity/selectivity, linearity, range, the limit of detection (LOD), and limit of quantitation (LOQ).
Findings/Results: Ethanolic extract of SHT exerted inhibitory activity on PGE2 production in RAW264.7 cells with IC50 16.97 ± 1.16 mg/mL. Myristica frangrans seed extract showed the highest inhibitory activity on PGE2 production. Piper retrofractum extract showed the highest inhibitory activity on TNF-α production. For the HPLC method, all validated parameters complied with standard requirements. Each analyzed peak showed good selectivity with a baseline resolution greater than 1.51. The linearity of all compounds was > 0.999. The % recovery of all compounds was within 98.0-102.0%. The precision of all compounds was less than 2.0% CV.
Conclusion and implications: Ethanolic extracts of SHT possess anti-inflammatory activity by inhibition of TNF-α and PGE2 production in vitro. This study provides support for the traditional use of SHT. The validated results showed good specificity/selectivity, linearity, precision, and accuracy with appropriate LOD and LOQ. This study is the first report on the validation of the HPLC method of SHT for use as quality control of the SHT extract.
Keywords
Full Text:
PDFReferences
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017;9(6):7204-7218.
DOI: 10.18632/oncotarget.23208.
Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020;180:114147,1-22.
DOI: 10.1016/j.bcp.2020.114147.
Khunsopitbunnalak. Khum-Pee-Pad-Thai-PanBo-Lan. 2nd ed. Bangkok: Ministry Publishing; 1970. pp. 267.
Announcement of the National Drug System Development Board on National List of Essential Medicines 2020. Royal Thai Government Gazette. 2020 [cited 2020 Dec 3];137:254D. Available from: http://www.ratchakitcha.soc.go.th/DATA/PDF/2563/E/254/T_0003.PDF.
Kakatum N, Jaiarree N, Makchucit S, Itharat A. Antioxidant and anti-inflammatory activities of Thai medicinal plants in Sahasthara remedy for muscle pain treatment. J Med Assoc Thai. 2012;95(Suppl 1):S120-S126.
Asasutjarit R, Sookdee P, Veeranondha S, Fuongfuchat A, Itharat A. Application of film-forming solution as a transdermal delivery system of piperine-rich herbal mixture extract for anti-inflammation. Heliyon. 2020;6(6):e04139,1-11.
DOI: 10.1016/j.heliyon.2020.e04139.
Kanokkangsadal P, Wanichsetakul P, Itharat A. The stability of Sahastara remedy ethanolic extract used for application in clinical study. Thammasat Med J. 2018;18(4):519-527.
Nuengchamnong N, Ingkaninan K. An on-line LC-MS/ DPPH approach towards the quality control of antioxidative ingredients in Sahastara. Songklanakarin J Sci Technol. 2017;39(1):123-129.
DOI: 10.14456/sjst-psu.2017.14.
Makchuchit S, Rattarom R, Itharat A. The anti-allergic and anti-inflammatory effects of Benjakul extract (a Thai traditional medicine), its constituent plants and its some pure constituents using in vitro experiments. Biomed Pharmacother. 2017;89:1018-1026.
DOI: 10.1016/j.biopha.2017.02.066.
ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology Q2(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Geneva, 2005:1-13.
Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986-1000.
DOI: 10.1161/ATVBAHA.110.207449.
Pinsornsak P, Kanokkangsadal P, Itharat A. The clinical efficacy and safety of the Sahastara remedy versus diclofenac in the treatment of osteoarthritis of the knee: a double-blind, randomized, and controlled trial. Evid Based Complement Alternat Med. 2015;2015:103046,1-8.
DOI: 10.1155/2015/103046.
Tanaka M, Kishimoto Y, Sasaki M, Sato A, Kamiya T, Kondo K, et al. Terminalia bellirica (Gaertn.) Roxb. Extract and gallic acid attenuate LPS-induced inflammation and oxidative stress via MAPK/NFB and Akt/AMPK/Nrf2 pathways. Oxid Med Cell Longev. 2018;2018:9364364,1-15.
DOI: 10.1155/2018/9364364.
Jaisi A, Sakunphueak A, Panichayupakaranant P. Increased production of plumbagin in Plumbago indica root cultures by gamma ray irradiation. Pharm Biol. 2013;51(8):1047-1051.
DOI: 10.3109/13880209.2013.775163.
Meghwal M, Goswami TK. Piper nigrum and piperine: an update. Phytother Res. 2013;27(8):1121-1130.
DOI: 10.1002/ptr.4972.
Das BK, Swamy AV, Koti BC, Gadad PC. Experimental evidence for use of Acorus calamus(asarone) for cancer chemoprevention. Heliyon. 2019;5(5):e01585,1-10.
DOI: 10.1016/j.heliyon.2019.e01585.
Bang JS, Oh DH, Choi HM, Sur BJ, Lim SJ, Kim JY, et al. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther. 2009;11(2):R49,1-9.
DOI: 10.1186/ar2662.
Liu Y, Yadev VR, Aggarwal BB, Nair MG. Inhibitory effects of black pepper (Piper nigrum) extracts and compounds on human tumor cell proliferation, cyclooxygenase enzymes, lipid peroxidation and nuclear transcription factor-kappa-B. Nat Prod Commun. 2010;5(8):1253-1257.
Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. Evaluation of the anti-inflammatory effects of ellagic acid. J Perianesth Nurs. 2010;25(4):214-220.
DOI: 10.1016/j.jopan.2010.05.011.
Tsang MS, Jiao D, Chan BC, Hon KL, Leung PC, Lau CB, et al. Anti-Inflammatory activities of pentaherbs formula, berberine, gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation. Molecules. 2016;21(4):519-539.
DOI: 10.3390/molecules21040519.
BenSaad LA, Kim KH, Quah CC, Kim WR, Shahimi M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement Altern Med. 2017;17:47-56.
DOI: 10.1186/s12906-017-1555-0.
Kim DY, Lee SH, Kim WJ, Jiang J, Kim MK, Shin YK, et al. Inhibitory effects of Acorus calamus extracts on mast cell-dependent anaphylactic reactions using mast cell and mouse model. J Ethnopharmacol. 2012;141(1):526-529.
DOI:10.1016/j.jep.2012.01.043.
Kim H, Han TH, Lee SG. Anti-inflammatory activity of a water extract of Acorus calamus L. leaves on keratinocyte HaCaT cells. J Ethnopharmacol. 2009;122(1):149-156.
DOI: 10.1016/j.jep.2008.12.011.
Luo P, Wong YF, Ge L, Zhang ZF, Liu Y, Liu L, et al. Anti-inflammatory and analgesic effect of plumbagin through inhibition of nuclear factor-κB activation. J Pharmacol Exp Ther. 2010;335(3):735-742.
DOI: 10.1124/jpet.110.170852.
Pinkaew D, Kiattisin K, Wonglangka K, Awoot P. Efficacy and safety of Phyllanthus amarus cream treatment in knee osteoarthritis. Open Sports Sci J. 2020;13:97-104.
DOI: 10.2174/1875399X02013010097.
Schell J, Scofield RH, Barrett JR, Kurien BT, Betts N, Lyons TJ, et al. Strawberries improve pain and inflammation in obese adults with radiographic evidence of knee osteoarthritis. Nutrients. 2017;9(9):949-961.
DOI: 10.3390/nu9090949.
Rachawat P, Pinsornsak P, Kanokkangsadal P, Itharat A. Clinical efficacy and safety of Benjakul remedy extract for treating primary osteoarthritis of knee compared with diclofenac: double blind, randomized controlled trial. Evid Based Complement Alternat Med. 2017;2017:9593580,1-9.
DOI: 10.1155/2017/9593580.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.